Clinical Trials Logo

Anaphylaxis clinical trials

View clinical trials related to Anaphylaxis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06065137 Not yet recruiting - Hypersensitivity Clinical Trials

Standardised Drug Provocation Testing in Perioperative Hypersensitivity

Start date: October 31, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and outcome of systematic drug provocation testing with anaesthetics at therapeutic doses in adult patients undergoing diagnostic work-up for perioperative hypersensitivity.

NCT ID: NCT06013150 Not yet recruiting - Clinical trials for Anaphylactic Reaction

Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.

Start date: October 23, 2023
Phase: Phase 1
Study type: Interventional

This is a phase 1, randomised, double blind placebo controlled 2-part study to assess the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of inhaled DMC-IH1 (epinephrine) and relative bioavailability and carryover effects of Inhaled (DMC-IH1) and Intramuscular(IM) (EpiPen®) Epinephrine in healthy male and female participants.

NCT ID: NCT05404165 Not yet recruiting - Clinical trials for Severe Anaphylactic Reaction, Self-administration, Adrenaline, Self-assessment

Relevance of the Self-assessment of Skills for Self-administration of Adrenaline by Auto-injectors in Patients at Risk of Severe Anaphylactic Reaction (PacAdré)

PacAdré
Start date: May 23, 2022
Phase:
Study type: Observational

To investigate the correlation between self-assessment by patients and an assessment by a health professional of the skills needed for self administration of adrenaline by auto-injectors. These skills include the identification of situations requiring the administration of adrenaline and the technical abilities to achieve it. Hypothesis: A self-assessment correlated with an external assessment would make it easier to adjust the frequency of therapeutic education sessions based on the patient's self-assessment alone.

NCT ID: NCT04825158 Not yet recruiting - Clinical trials for Perioperative Complication

Study of the Role of Hemostasis in Perioperative Anaphylaxis

HEMOCANOPE
Start date: April 1, 2021
Phase:
Study type: Observational

Anaphylaxis is a severe and life-threatening complication during the perioperative period. Perioperative anaphylaxis is still associated with a significant mortality despite quick and efficient management using epinephrine, the mainstay of acute treatment. Experimental data and few case reports are suggesting that hemostasis, and more precisely platelets, could play a role in anaphylaxis. Our main hypothesis is that activation of the hemostatic system contributes to the severity of the reaction

NCT ID: NCT04475003 Not yet recruiting - Health Literacy Clinical Trials

Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis

Start date: September 30, 2020
Phase:
Study type: Observational

Research on health literacy among caregivers of children with IgE-mediated allergy at risk of anaphylaxis (life-threatening allergic reaction). Health literacy is a person's ability to understand health information so that they can maintain or improve their health and quality of life (of themself and children). The aim of the study is to test the general knowledge of anaphylaxis. Furthermore we test the extent to which caregivers consider themselves able to recognize and to treat anaphylaxis.

NCT ID: NCT03553251 Not yet recruiting - Hypersensitivity Clinical Trials

Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.

TRO-b-lact
Start date: July 30, 2018
Phase:
Study type: Observational

The purpose of this study is to establish the rationale for the practice of performing an oral reintroduction test without previous skin tests in children at low risk of IgE-mediated reaction or drug-induced toxidermia, and to confirm the criteria for a drug reintroduction test could be performed without previous skin tests, without subsequent risk of reaction for the child. The primary endpoint will be the risk of a severe IgE-mediated or delayed hypersensitivity reaction in children who received beta-lactam drug reintroduction protocol prior to skin testing.

NCT ID: NCT01314573 Not yet recruiting - Clinical trials for Exercise Anaphylaxis

The Impact of High Intensity Exercise Upon EPC Number and Function in Young Women

Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the effects of different exercise intensity training programs upon blood vessel function and circulating blood cells involved in blood vessel repair in young women. The long term effects of exercise may be beneficial to cardiovascular health and it is important to understand the training methods that are the most beneficial. In particular we aim to determine if brief maximal exercise improves the function and stiffness of blood vessels and enhance blood vessel repair. Two methods of exercising are being compared, exercise bouts involving intermittent exercise and exercise completed all at once, but at a very high intensity.